Prognostic significance and clinical determinants of residual dyspnoea at discharge in acute heart failure: a single-centre, prospective observational study.

Garus, Mateusz; Jura, Maksym; Guzik, Mateusz; Zymliński, Robert; Iwanek, Gracjan; Ponikowski, Piotr; Biegus, Jan · BMJ Open · 2023

prospective_cohort · Level II

Where this comes from

Abstract

This study aimed to assess the prognostic significance of residual (discharge) dyspnoea in acute heart failure (AHF) patients. Single-centre, prospective observational study. Patients hospitalised for decompensated AHF in a single cardiology centre, in Poland. All patients (n=202) who survived the hospitalisation with the primary diagnosis of AHF and were discharged from the hospital. 1-year all-cause mortality; and the composite endpoint of 1-year all-cause mortality and rehospitalisation for the HF (whichever occurred first). On admission, 159 (78.7%) AHF patients presented dyspnoea at rest, while residual resting dyspnoea at discharge was present in 16 patients (7.9%). There were 48 (24%) patients with moderate/severe exertional dyspnoea at discharge. In the multivariable model, the resting dyspnoea at discharge was related to a higher risk of both 1-year mortality and composite outcome, with HR (95% CI) 8.0 (3.7 to 17.3) and 5.1 (2.6 to 10.2), respectively, both p<0.0001. Analogically, moderate or severe residual dyspnoea at discharge was related to the heightened risk of study both outcomes, with HR (95% CI) 3.1 (1.8 to 5.4) and 1.8 (1.1 to 2.9), respectively, p<0.01. Among AHF patients the residual dyspnoea at discharge was unexpectedly common and was associated with an unfavourable outcome during 1-year follow-up.

Medical subject headings